THIS INFORMATION STATEMENT IS BEING PROVIDED
TO
YOU BY THE BOARD OF DIRECTORS OF PERVASIP
CORP.
WE ARE NOT ASKING YOU FOR A PROXY AND
YOU ARE
REQUESTED NOT TO SEND US A PROXY
PERVASIP CORP.
430 North Street
White Plains, New York 10601
(914) 620-1500
INFORMATION STATEMENT
(Preliminary)
October 21, 2013
GENERAL INFORMATION
To the Holders of Common Stock of Pervasip
Corp:
This Information Statement has been
filed with the Securities and Exchange Commission and is being furnished, pursuant to Section 14C of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), to the holders (the “Stockholders”) of common stock, par value
$0.001 per share (the “Common Stock”), of Pervasip Corp, a New York corporation (the “Company”), to notify
the Stockholders that on October 7, 2013, the Company received a unanimous written consent in lieu of a meeting of the holders
of Series D Preferred Stock, par value $0.001 per share (the “Series D Preferred”). Each share of Series D Preferred
has the equivalent of 16,315,625 votes of Common Stock (based upon the outstanding number of shares of Common Stock issued at the
time hereof). Currently, there are two holders of Series D Preferred (collectively, the “Series D Stockholders” or
the “Majority Stockholders”), together holding fifty-one (51) shares of Series D Preferred, resulting in the Series
D Stockholders holding in the aggregate 51% of the total voting power of all issued and outstanding voting capital of the Company.
The Series D Stockholders authorized the following:
|
·
|
The increase in the number of authorized
shares of Common Stock from 800,000,000 shares of Common Stock to 1,500,000,000 shares of Common Stock (the “Authorized Share
Increase”).
|
On October 7, 2013, the Board approved the
Authorized Share Increase and recommended to the Majority Stockholders that they approve the Authorized Share Increase. On October
7, 2013, the Majority Stockholders approved the Authorized Share Increase by written consent in lieu of a meeting in accordance
with New York law. Accordingly, your consent is not required and is not being solicited in connection with the approval
of the Actions.
We will mail the Notice of Stockholder
Action by Written Consent to the Stockholders on or about October 31, 2013.
WE ARE NOT ASKING YOU FOR A PROXY
AND YOU ARE REQUESTED NOT TO SEND A PROXY.
The Board believes the Authorized Share
Increase is necessary and advisable in order to maintain the Company’s financing and capital raising ability and to generally
maintain our flexibility in today’s competitive and rapidly changing environment.
Accordingly, it is the Board’s
opinion that the Authorized Share Increase would better position the Company to attract potential business candidates and provide
the Stockholders a greater potential return.
INTRODUCTION
New York law provides that the
written consent of the holders of outstanding shares of voting capital stock having not less than the minimum number of votes
which would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were
present and voted can approve an action in lieu of conducting a special stockholders' meeting convened for the specific
purpose of such action. On October 7, 2013, the Board approved the Authorized Share Increase and recommended to the Majority
Stockholders that they approve the Authorized Share Increase. On October 7, 2013, the Majority Stockholders approved the
Authorized Share Increase by written consent in lieu of a meeting in accordance with New York law.
In accordance with the foregoing, we will mail
the Notice of Stockholder Action by Written Consent on or about October 31, 2013.
This Information Statement contains
a brief summary of the material aspects of the Actions approved by the Board of Pervasip Corp. (the “Company,” “we,”
“our,” or “us”) and the holders of Series D Preferred Stock (the “Series D Preferred”), which
constitute a majority of the voting capital stock of the Company.
Series D Preferred
By unanimous written consent of the
Board (as permitted under New York law), the number, designation, rights, preferences and privileges of the Series D Preferred
were established by the Board (as is permitted under New York law and by the Amended Certificate of Incorporation of the Company).
The designation, rights, preferences and privileges that the Board established for the Series D Preferred is set forth in a Certificate
of Amendment of the Certificate of Incorporation that was filed with the Department of State of the State of New York on August
30, 2013. Among other things, the Certificate of Amendment of the Certificate of Incorporation provides that each one share of
Series D Preferred has voting rights equal to (x) 0.019607
multiplied by
the total issued and outstanding Common Stock eligible
to vote at the time of the respective vote (the “Numerator”),
divided by
(y) 0.49,
minus
(z) the Numerator.
By unanimous written consent of the
Board, the Board issued an aggregate of fifty-one (51) shares of Series D Preferred to two individuals
(together, the “Series
D Stockholders”). As a result of the voting rights granted to the Series D Preferred, the Series D Stockholders hold in the
aggregate 51% of the total voting power of all issued and outstanding voting capital of the Company.
As of October 7, 2013, there were issued
and outstanding (i) 799,499,997 shares of our Common Stock, (ii) zero shares of our Series A Preferred Stock, (iii) zero shares
of our Series B Preferred Stock, (iv) zero shares of our Series C Preferred Stock and (v) fifty-one (51) shares of our Series D
Preferred. Based on the foregoing, the total aggregate amount of votes entitled to vote regarding the approval of the Authorized
Share Increase approved by the Board is 1,631,596,865 (the sum of the votes represented by the issued and outstanding shares of
Common Stock and Series D Preferred). Pursuant to New York law, at least a majority of the voting equity of the Company, or at
least 815,798,434 votes, are required to approve the Actions by written consent. The Series D Stockholders, which hold in the aggregate
fifty-one (51) shares of Preferred Stock, or 51% of the voting equity of the Company, have voted in favor of the Actions, thereby
satisfying the requirement under New York law that at least a majority of the voting equity vote in favor of a corporate action
by written consent.
The following table sets forth the name
of the Series D Stockholders, the number of shares of Series D Preferred held by each Series D Stockholder, the total number of
votes that the Series D Stockholders voted in favor of the Actions and the percentage of the issued and outstanding voting equity
of the Company that voted in favor thereof.
Name of Series D Stockholder
|
Number of Shares of Series D Preferred
held
|
Number of Votes held by such Series D Stockholder
|
Number of Votes that Voted in favor of the Actions
|
Percentage of the Voting Equity that Voted in favor of the Actions
|
Paul H. Riss
|
48
|
783,149,994
|
783,149,994
|
48%
|
Mark Richards
|
3
|
48,946,875
|
49,946,875
|
3%
|
ACTIONS TO BE TAKEN
The Authorized Share Increase will
become effective on the date that we file the Certificate of Amendment to the Amended Certificate of Incorporation of the Company
(the “Amendment”) with the Department of State of the State of New York. We intend to file the Amendment with the Department
of State of the State of New York promptly after the twentieth (20
th
) day following the date on which this Information
Statement is mailed to the Stockholders.
INCREASE IN THE NUMBER OF AUTHORIZED
SHARES
OF COMMON STOCK
GENERAL
The number of authorized shares of our
Common Stock will be increased from 800,000,000 shares to 1,500,000,000 shares of Common Stock (the “Authorized Share Increase”).
PURPOSE AND EFFECT OF INCREASING
THE NUMBER OF AUTHORIZED SHARES
The Board believes the Authorized
Share Increase is necessary and advisable in order to maintain our financing and capital raising ability and to generally maintain
our flexibility in today’s competitive and rapidly changing environment. The additional 700,000,000 shares of Common Stock
so authorized will be available for issuance by the Board for stock splits or stock dividends, acquisitions, raising additional
capital, stock options or other corporate purposes. The additional shares of Common Stock could be used for potential strategic
transactions, including, among other things, acquisitions, strategic partnerships, joint ventures, restructurings, business combinations
and investments, although there are no immediate plans to do so. Assurances cannot be provided that any such transactions will
be consummated on favorable terms or at all, that they will enhance stockholder value or that they will not adversely affect the
Company’s business or the trading price of the Common Stock. Other than issuances pursuant to employee benefit plans and
currently outstanding stock options, exercisable warrants and convertible debentures, the Board has no current plans to issue any
of the additional shares of Common Stock that would be authorized by this proposal. The Company does not anticipate that it would
seek authorization from the stockholders for issuance of such additional shares unless required by applicable law or regulations.
The increase in the authorized number
of shares of Common Stock and any subsequent issuance of such shares could have the effect of delaying or preventing a change in
control of the Company without further action by the stockholders. Shares of authorized and unissued Common Stock could (within
the limits imposed by applicable law and stock exchange regulations) be issued in one or more transactions, which would make a
change in control of the Company more difficult, and therefore less likely. Any such issuance of the additional shares of Common
Stock could have the effect of diluting the earnings per share and book value per share of outstanding shares of Common Stock,
and such additional shares could be used to dilute the stock ownership or voting rights of a person seeking to obtain control of
the Company. The Board is not aware of any attempt to take control of the Company and has not presented this proposal with the
intention that the increase in the number of authorized shares of Common stock be used as a type of antitakeover device. Any additional
Common Stock, when issued, would have the same rights and preferences as the shares of Common Stock presently outstanding.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT
The following tables set forth certain
information regarding the beneficial ownership of our Common Stock as of October 8, 2013 of (i) each person known to us to
beneficially own more than 10% of Common Stock, (ii) our directors, (iii) each named executive officer and (iv) all directors
and named executive officers as a group. As of October 8, 2013, there were a total of 799,499,997
shares of Common
Stock outstanding. Each share of Common Stock is entitled to one vote on matters on which holders of voting stock of the Company
are eligible to vote. The column entitled “Percentage of Total Voting Stock” shows the percentage of total
voting stock beneficially owned by each listed party.
The number of shares beneficially owned
is determined under the rules promulgated by the SEC, and the information is not necessarily indicative of beneficial ownership
for any other purpose. Under those rules, beneficial ownership includes any shares as to which a person or entity has
sole or shared voting power or investment power
plus
any shares which such person or entity has the right to acquire within
sixty (60) days of October 8, 2013 through the exercise or conversion of any stock option, convertible security, warrant or other
right. Unless otherwise indicated, each person or entity named in the table has sole voting power and investment power
(or shares such power with that person’s spouse) with respect to all shares of capital stock listed as owned by that person
or entity.
|
|
Number of Shares of Common Stock Beneficially Owned
|
|
|
Percent of Shares
of Common Stock
Beneficially Owned
|
|
Number of Shares
of Series D
Preferred Stock
Beneficially
Owned
(6)
|
|
Percent of Shares
of Series D
Preferred Stock
Beneficially Owned
|
G3 Connect, LLC
321 Newark Street 3
rd
Floor
Hoboken, NJ 07030
|
|
|
96,947,250
|
|
|
|
12.13
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul H. Riss
Pervasip Corp.
75 South Broadway, Suite 400
White Plains, New York 10601
|
|
|
49,938,533
|
(1)
|
|
|
5.84
|
%
|
|
|
48
|
(7)
|
|
|
94.12
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mark Richards
Pervasip Corp.
75 South Broadway, Suite 400
White Plains, New York 10601
|
|
|
27,774,333
|
(2)
|
|
|
3.38
|
%
|
|
|
3
|
(8)
|
|
|
5.88
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Greg M. Cooper
Cooper, Niemann & Co., CPAs, LLP
PO Box 190
Mongaup Valley, New York 12762
|
|
|
338,333
|
(3)
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Scott Widham
Pervasip Corp.
75 South Broadway, Suite 400
White Plains, New York 10601
|
|
|
334,333
|
(4)
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cherian Mathai
Pervasip Corp.
75 South Broadway, Suite 400
White Plains, New York 10601
|
|
|
334,333
|
(5)
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All directors and executive officers as a group (five individuals)
|
|
|
78,719,866
|
|
|
|
9.20
|
%
|
|
|
51
|
|
|
|
100
|
%
|
__________________
* Less than 1%.
(1)
|
Includes 32,906,000 shares of common stock subject to options and warrants that are presently exercisable or exercisable within 60 days after October 8, 2013.
|
(2)
|
Includes 21,550,000 shares of common stock subject to options and warrants that are presently exercisable or exercisable within 60 days after October 8, 2013.
|
(3)
|
Includes 338,333 shares of common stock subject to options that are presently exercisable or exercisable within 60 days after October 8, 2013.
|
(4)
|
Includes 334,333 shares of common stock subject to options that are presently exercisable or exercisable within 60 days after October 8, 2013.
|
(5)
|
Includes 334,333 shares of common stock subject to options that are presently exercisable or exercisable within 60 days after October 8, 2013.
|
(6)
|
Each one share of Series D Preferred has voting rights equal to (x) 0.019607
multiplied by
the total issued and outstanding Common Stock eligible to vote at the time of the respective vote (the “Numerator”),
divided by
(y) 0.49,
minus
(z) the Numerator.
|
(7)
|
Mr. Paul Riss owns 48 shares of Series D Preferred Stock, which is representative of 783,149,994 shares solely for voting purposes.
|
(8)
|
Mr. Mark Richards owns 3 shares of Series D Preferred Stock, which is representative of 48,946,875 shares solely for voting purposes.
|
ADDITIONAL INFORMATION
We are subject to the disclosure requirements
of the Securities Exchange Act of 1934, as amended, and in accordance therewith, file reports, information statements and other
information, including annual and quarterly reports on Form 10-K and 10-Q, respectively, with the Securities and Exchange Commission
(the “SEC”). Reports and other information filed by the Company can be inspected and copied at the public reference
facilities maintained by the SEC at 100 F Street, N.E., Washington, DC 20549. Copies of such material can also be obtained upon
written request addressed to the SEC, Public Reference Section, 100 F Street, N.E., Washington, D.C. 20549 at prescribed rates.
In addition, the SEC maintains a web site on the Internet (http://www.sec.gov) that contains reports, information statements and
other information regarding issuers that file electronically with the SEC through the Electronic Data Gathering, Analysis and Retrieval
System.
The following documents, as filed with
the SEC by the Company, are incorporated herein by reference:
|
(1)
|
Annual Report on Form 10-K for the fiscal year ended November 30, 2012;
|
|
(2)
|
Quarterly Reports on Form 10-Q for the three months ended February 28, 2013 and May 31, 2013; and
|
|
(3)
|
Current Reports on Form 8-K, as filed
with the SEC on February 4, 2013, February 19, 2013, March 6, 2013, June 21, 2013, June 28, 2013 and September 6, 2013, respectively.
|
You may request a copy of these filings,
at no cost, by writing Pervasip Corp. at 75 South Broadway, Suite 400, White Plains, New York 10601 or telephoning the Company
at (914) 620-1500. Any statement contained in a document that is incorporated by reference will be modified or superseded for all
purposes to the extent that a statement contained in this Information Statement (or in any other document that is subsequently
filed with the SEC and incorporated by reference) modifies or is contrary to such previous statement. Any statement so modified
or superseded will not be deemed a part of this Information Statement except as so modified or superseded.
DELIVERY OF DOCUMENTS TO SECURITY
HOLDERS SHARING AN ADDRESS
If hard copies of the materials are
requested, we will send only one Information Statement and other corporate mailings to stockholders who share a single address
unless we received contrary instructions from any stockholder at that address. This practice, known as “householding,”
is designed to reduce our printing and postage costs. However, the Company will deliver promptly upon written or oral request a
separate copy of the Information Statement to a stockholder at a shared address to which a single copy of the Information Statement
was delivered. You may make such a written or oral request by (a) sending a written notification stating (i) your name, (ii) your
shared address and (iii) the address to which the Company should direct the additional copy of the Information Statement, to the
Company at 430 North Street, White Plains, New York 10601, telephone: (914) 620-1500.
If multiple stockholders sharing an
address have received one copy of this Information Statement or any other corporate mailing and would prefer the Company to mail
each stockholder a separate copy of future mailings, you may mail notification to, or call the Company at, its principal executive
offices. Additionally, if current stockholders with a shared address received multiple copies of this Information Statement or
other corporate mailings and would prefer the Company to mail one copy of future mailings to stockholders at the shared address,
notification of such request may also be made by mail or telephone to the Company’s principal executive offices.
This Information Statement is provided
to the holders of Common Stock of the Company only for information purposes in connection with the Actions, pursuant to and in
accordance with Rule 14c-2 of the Exchange Act. Please carefully read this Information Statement.
By Order of the Board of Directors
|
|
|
|
|
|
|
|
|
/s/Paul H. Riss
Chief Executive Officer
Dated: October 21, 2013